Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent
A technology of biphenyl cyclooctadiene lignan and biphenyl cyclooctadiene is applied in the application field of biphenyl cyclooctadiene lignan in reducing the toxic and side effects of antineoplastic drugs, and can solve the problem of unseen antineoplastic drugs. To achieve good effects, improve heart function, and reduce toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1: Study on the Prevention of Cardiotoxicity Caused by Adriamycin with Schizandrin B (SchB)
[0048] 1 Materials and methods
[0049] 1.1 Experimental materials: doxorubicin hydrochloride for injection, Italian pharmacia company, batch number: 5E2002-D, SchB, China Institute for the Control of Pharmaceutical and Biological Products, batch number: 110765-200407, dissolved in 0.5% poloxamer. CK, CK-MB, LDH, and GOT were detected by a fully automatic biochemical analyzer. Tissue protein extract, Pierce Company, USA. ICR male mice, weighing 25-30 g, were provided by Shanghai Experimental Animal Center.
[0050] 1.2 Test grouping and administration
[0051] The 162 animals were divided into 6 groups by random grouping method:
[0052] 24 rats in the blank control group were given normal saline 20ml / kg / time by intragastric administration on the 1st to 3rd day of the experiment, once a day, and intraperitoneally injected once within 2 hours after the intragastric a...
Embodiment 2
[0072] Example 2: The preventive effect of five biphenyl cyclooctadiene lignans on other toxic and side effects of doxorubicin
[0073] 1 Materials and methods
[0074] 1.1 Experimental materials: doxorubicin hydrochloride for injection, Italian pharmacia company. Five kinds of biphenyl cyclooctadiene lignans, China Institute for the Control of Pharmaceutical and Biological Products, batch number: 110765-200407. Dissolved in 0.5% poloxamer. ICR female mice, weighing 20-25 g, provided by Shanghai Experimental Animal Center, were randomly divided into groups as follows, with 10 mice in each group.
[0075] 1.2 Animal grouping and drug administration methods and routes
[0076] 10 rats in the control group were injected with normal saline intraperitoneally, once every other day, for 7 consecutive times;
[0077] Adriamycin group (Dox group) 10 rats, Adriamycin 2mg / kg, intraperitoneal injection, once every other day, 7 times in a row;
[0078] Doxorubicin + Schizandrin B 1 gro...
Embodiment 3
[0092] Embodiment 3: 6 kinds of biphenyl cyclooctane lignans reduce the cardiotoxicity caused by daunorubicin
[0093]Experimental method: ICR mice were purchased from Shanghai Experimental Animal Center. Schizandrin A, Schizandrin B, Schizandrin C, Schisandrin ester A, Schisandrol A, Schisandrin B were prepared with 0.5% poloxamer to prepare 1 g / ml mother liquor. The animals were divided into 7 groups, 15 in each group, each mouse in group 1 was given 100 μl solvent (0.5% poloxamer), each mouse in group 2 was given 100 μl schisandrin A, each mouse in group 3 was given 100 μl schisandrin B in stomach, 100 μl schisandrin C in each mouse in group 4, 100 μl schisandrin A in group 5, 100 μl schisandrin A in group 6, each mouse in group 7 Rats were gavaged with 100 μl Schisandra Alcohol B; 3 hours later, the mice were injected with daunorubicin (4 mg / kg) into the tail vein; the drug was given once every 7 days, for a total of 10 times. One week after the last dose, the mice were ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com